Valuation: Galenica AG

Market Cap 4.22B 5.22B 4.52B 3.88B 7.32B 497B 7.4B 49.56B 19.45B 249B 19.62B 19.19B 823B P/E 2026 *
24.7x
P/E 2027 * 20.4x
Enterprise Value 5.15B 6.37B 5.52B 4.73B 8.93B 606B 9.03B 60.46B 23.73B 303B 23.94B 23.41B 1,004B EV / Sales 2026 *
1.17x
EV / Sales 2027 * 1.12x
Free-Float
99.39%
Yield 2026 *
3.02%
Yield 2027 * 3.18%
1 day-1.92%
1 week-2.05%
Current month-0.73%
1 month+0.00%
3 months+3.93%
6 months-13.12%
Current year-12.03%
1 week 83.35
Extreme 83.35
88.85
1 month 83.35
Extreme 83.35
90
Current year 81.3
Extreme 81.3
103
1 year 81.3
Extreme 81.3
103
3 years 65.2
Extreme 65.2
103
5 years 60.65
Extreme 60.65
103
10 years 39
Extreme 39
103
Manager TitleAgeSince
Chief Executive Officer 59 2020-03-31
Director of Finance/CFO 44 2024-12-31
Chief Tech/Sci/R&D Officer 54 2021-12-31
Director TitleAgeSince
Director/Board Member 61 2017-12-31
Chairman 68 2023-05-02
Director/Board Member 49 2019-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.27%-2.05% - - 5.21B
+4.29%-2.99%+21.49%+104.14% 97.22B
+2.18%+4.29%+51.00%+159.10% 54.7B
+0.34%+2.76%+3.83%+282.05% 24.02B
-1.02%+0.06%-14.23%-17.62% 8.27B
-2.00%-3.42%-36.20%-32.35% 7.4B
-0.52%+0.06%-7.70%-29.84% 6.9B
+2.52%-1.61%+19.32%+18.57% 6.03B
-2.96%-2.19%-9.58%-8.39% 3.74B
-1.93%-8.65%+8.06%+16.53% 3.59B
Average -0.09%-2.85%+4.00%+54.69% 23.54B
Weighted average by Cap. +2.38%-3.20%+21.91%+118.71%

Financials

2026 *2027 *
Net sales 4.4B 5.45B 4.72B 4.04B 7.63B 518B 7.72B 51.67B 20.28B 259B 20.45B 20B 858B 4.53B 5.61B 4.86B 4.17B 7.87B 534B 7.96B 53.25B 20.9B 267B 21.08B 20.61B 884B
Net income 181M 224M 194M 166M 314M 21.3B 318M 2.13B 834M 10.66B 841M 823M 35.3B 208M 257M 223M 191M 360M 24.45B 364M 2.44B 957M 12.23B 966M 944M 40.51B
Net Debt 928M 1.15B 995M 853M 1.61B 109B 1.63B 10.9B 4.28B 54.66B 4.31B 4.22B 181B 869M 1.08B 932M 799M 1.51B 102B 1.52B 10.21B 4.01B 51.18B 4.04B 3.95B 170B
Logo Galenica AG
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Employees
6,577
Date Price Change Volume
26-08-05 CHF 84.65 +0.35% 106,286
26-08-04 CHF 84.35 -0.90% 6,833
26-08-03 CHF 85.12 -1.70% 15,812
26-07-31 CHF 86.58 -1.44% 25,068
26-07-30 CHF 87.85 -0.38% 55,869
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
84.60CHF
Average target price
87.20CHF
Spread / Average Target
+3.07%

Quarterly revenue - Rate of surprise